Helix BioPharma (HBP) Competitors C$0.80 0.00 (0.00%) As of 04/1/2025 09:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock HBP vs. BCT, IPA, SCYB, COM, NVH, IGX, MDNA, TH, ONC, and PDPShould you be buying Helix BioPharma stock or one of its competitors? The main competitors of Helix BioPharma include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Medicenna Therapeutics (MDNA), Theratechnologies (TH), Oncolytics Biotech (ONC), and Pediapharm (PDP). These companies are all part of the "biotechnology" industry. Helix BioPharma vs. BriaCell Therapeutics ImmunoPrecise Antibodies Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies Medicenna Therapeutics Theratechnologies Oncolytics Biotech Pediapharm Helix BioPharma (TSE:HBP) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, community ranking, risk and valuation. Is HBP or BCT more profitable? Helix BioPharma's return on equity of 1,803.57% beat BriaCell Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Helix BioPharmaN/A 1,803.57% -279.98% BriaCell Therapeutics N/A N/A N/A Does the media refer more to HBP or BCT? In the previous week, Helix BioPharma's average media sentiment score of 0.00 equaled BriaCell Therapeutics'average media sentiment score. Company Overall Sentiment Helix BioPharma Neutral BriaCell Therapeutics Neutral Which has stronger valuation and earnings, HBP or BCT? BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Helix BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHelix BioPharmaN/AN/A-C$50.55M-C$0.95-0.84BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19 Does the MarketBeat Community believe in HBP or BCT? Helix BioPharma received 26 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 68.97% of users gave BriaCell Therapeutics an outperform vote while only 63.46% of users gave Helix BioPharma an outperform vote. CompanyUnderperformOutperformHelix BioPharmaOutperform Votes6663.46% Underperform Votes3836.54% BriaCell TherapeuticsOutperform Votes4068.97% Underperform Votes1831.03% SummaryHelix BioPharma and BriaCell Therapeutics tied by winning 3 of the 6 factors compared between the two stocks. Remove Ads Get Helix BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HBP and its competitors with MarketBeat's FREE daily newsletter. Email Address HBP vs. The Competition Export to ExcelMetricHelix BioPharmaBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$42.42MC$114.66MC$5.55BC$5.70BDividend Yield1.50%3.69%5.35%6.44%P/E Ratio-0.843.1223.4231.87Price / SalesN/A4,029.45363.77579.73Price / Cash11.3213.0138.1683.21Price / Book-5.7535.386.613.56Net Income-C$50.55M-C$87.82MC$3.20BC$299.69M7 Day PerformanceN/A-4.41%-5.01%-1.05%1 Month PerformanceN/A57.56%-1.58%-0.16%1 Year Performance344.44%85.27%8.59%14.01% Helix BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HBPHelix BioPharmaN/AC$0.80flatN/A+344.4%C$42.42MN/A-0.849BCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownSCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpMDNAMedicenna TherapeuticsN/AC$0.99flatN/A-46.4%C$74.07MC$4,868.39-2.7320News CoverageTHTheratechnologiesN/AC$2.21-2.2%N/A-1.4%C$70.51MC$52.22M-25.02103ONCOncolytics Biotech0.2333 of 5 starsC$0.91+2.2%C$3.50+284.6%-46.2%C$70.14MN/A-2.5429Negative NewsGap DownPDPPediapharmN/AC$0.30+1.7%N/A+0.0%C$66.36MC$11.16M-4.11N/A Remove Ads Related Companies and Tools Related Companies BriaCell Therapeutics Competitors ImmunoPrecise Antibodies Competitors Scythian Biosciences Competitors 138267 (COM.TO) Competitors Novoheart Competitors IntelGenx Technologies Competitors Medicenna Therapeutics Competitors Theratechnologies Competitors Oncolytics Biotech Competitors Pediapharm Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:HBP) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.